Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.

  • Konstantin Agelopoulos
  • Burkhard Greve
  • Hartmut Schmidt
  • Heike Pospisil
  • Stefan Kurtz
  • Kai Bartkowiak
  • Antje Andreas
  • Marek Wieczorek
  • Eberhard Korsching
  • Horst Buerger
  • Burkhard Brandt

Beteiligte Einrichtungen

Abstract

Increased transcription of oncogenes like the epidermal growth factor receptor (EGFR) is frequently caused by amplification of the whole gene or at least of regulatory sequences. Aim of this study was to pinpoint mechanistic parameters occurring during egfr copy number gains leading to a stable EGFR overexpression and high sensitivity to extracellular signalling. A deeper understanding of those marker events might improve early diagnosis of cancer in suspect lesions, early detection of cancer progression and the prediction of egfr targeted therapies.

Bibliografische Daten

OriginalspracheDeutsch
ISSN1471-2407
DOIs
StatusVeröffentlicht - 2010
pubmed 20199686